CureVac N.V. (CVAC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:45PM EDT. Market open.
| Previous close | 6.44 |
| Open | 6.53 |
| Bid | 6.73 x 900 |
| Ask | 6.74 x 800 |
| Day's range | 6.53 - 6.74 |
| 52-week range | 5.63 - 20.20 |
| Volume | |
| Avg. volume | 1,269,123 |
| Market cap | 1.492B |
| Beta (5Y monthly) | 2.97 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.65 |
| Earnings date | 26 Apr 2023 - 01 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 17.75 |
- Simply Wall St.
As CureVac N.V.'s market cap (NASDAQ:CVAC) drops to US$1.4b, insiders might be questioning their decision to buy earlier this year
The recent 7.1% drop in CureVac N.V.'s ( NASDAQ:CVAC ) stock could come as a blow to insiders who purchased €97m worth...
- Simply Wall St.
The past year for CureVac (NASDAQ:CVAC) investors has not been profitable
While it may not be enough for some shareholders, we think it is good to see the CureVac N.V. ( NASDAQ:CVAC ) share...
- Motley Fool
Why CureVac's Shares Jumped on Tuesday
Shares of CureVac (NASDAQ: CVAC) rose as much as 19.1% on Tuesday. Despite the rise, CureVac is down more than 59% over the past year, though it is now up more than 61% over the past three months. Investors continued to flock to the healthcare stock after the biotech announced late Friday that several of its messenger RNA vaccines were doing well in early trials.
© 2023 Yahoo. All rights reserved.
